What does InfoBionic do?
InfoBionic, is an emerging digital health company focused on creating superior monitoring solutions for managing chronic diseases. The company develops MoMe System, which is a patient monitoring platform which helps physicians in accurately diagnosing and treating patients. This is a remote patient monitoring pltatfom which focused initially on cardiac arrhythmia detection, for improving clinical efficiency and care of the patients with anytime, anywhere access to the patient data. The company has a dedicated and experienced team which combined the power of cloud computing with unprecedented arrhythmia detection to offer the company’s first product, MoMe Kardia.
How much InfoBionic was funded?
Infobionic raised $8M in Series B-1 funding on August 5, 2015 from Excel Venture Management, Zaffre Investments and Safeguard Scientifics
Previous funding
- Undisclosed amount in Seed round on December 12, 2012 from Fort Point Angels and Oleg Uritsky
- $969k in Seed round on December 20, 2012
- Undisclosed amount in Series A on March 11, 2013 from Beta Fund and HealthTech Capital
- $1.2M in Convertible Note on November 19, 2013 from Cherrystone Angel Group
- $17M in Series B funding on April 8, 2014 from Safeguard Scientifics(Lead) Partner: Al Wiegman, Boynton Angels, Broadview Ventures Partner: Maria Berkman, Beta Fund, HealthTech Capital, LaunchPad Venture Group, Keiretsu Forum, TiE Angels, Mass Medical Angels Partner: Carl Berke and Zaffre Investments.
What is next for InfoBionic?
The latest funding raised by the company will be used for supporting its ability to capitalize on the significant opportunity in the cardiac arrhythmia field and for commercializing its MoMe Kardia System, which is a remote patient monitoring platform for detecting cardiac arrhythmia.
More about InfoBionic
Infobionic was founded in 2011 by Jeremy Ruskin, Ravi Kuppuraj. It has its headquarters in Lowell, MA. This digital health company focuses on creating superior patient monitoring solutions for managing chronic diseases.